Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-23
DOI
10.1111/cns.12869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions
- (2017) Guo-Wang Lin et al. NEUROPHARMACOLOGY
- Unexplained Early Infantile Epileptic Encephalopathy in Han Chinese Children: Next-Generation Sequencing and Phenotype Enriching
- (2017) Ahmed Arafat et al. Scientific Reports
- De novo GABRG2mutations associated with epileptic encephalopathies
- (2016) Dingding Shen et al. BRAIN
- Novel SIL1 nonstop mutation in a Chinese consanguineous family with Marinesco-Sjögren syndrome and Dandy-Walker syndrome
- (2016) Nan Gai et al. CLINICA CHIMICA ACTA
- Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes
- (2016) Elena Parrini et al. HUMAN MUTATION
- Pyridoxine-dependent epilepsy: report on three families with neuropathology
- (2016) Florent Marguet et al. METABOLIC BRAIN DISEASE
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- Limits to Personalized Cancer Medicine
- (2016) Ian F. Tannock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder
- (2016) Amitha L. Ananth et al. PEDIATRIC NEUROLOGY
- SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures
- (2016) Samantha Palmer et al. PEDIATRIC NEUROLOGY
- Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations
- (2016) Yukiko Ihara et al. PLoS One
- Effectiveness of antiepileptic therapy in patients with PCDH19 mutations
- (2016) Jan Lotte et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Quinidine in the treatment of KCNT1-positive epilepsies
- (2015) Mohamad A Mikati et al. ANNALS OF NEUROLOGY
- Early and effective treatment ofKCNQ2encephalopathy
- (2015) Tiziana Pisano et al. EPILEPSIA
- SPTAN1 encephalopathy: distinct phenotypes and genotypes
- (2015) Jun Tohyama et al. JOURNAL OF HUMAN GENETICS
- A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach
- (2015) K. Dörre et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Epilepsy treatment: precision medicine at a crossroads
- (2015) Dick Lindhout LANCET NEUROLOGY
- The phenotypic spectrum of SCN8A encephalopathy
- (2015) J. Larsen et al. NEUROLOGY
- Association study between polymorphisms in the CACNA1A, CACNA1C, and CACNA1H genes and drug-resistant epilepsy in the Chinese Han population
- (2015) Nan Lv et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome
- (2014) P. B. Mills et al. BRAIN
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complex
- (2013) Darcy A. Krueger et al. ANNALS OF NEUROLOGY
- Gene-Wide Tagging Study of the Association BetweenKCNT1Polymorphisms and the Susceptibility and Efficacy of Genetic Generalized Epilepsy in Chinese Population
- (2013) Jian Qu et al. CNS Neuroscience & Therapeutics
- Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation
- (2013) Anders Helander et al. MOLECULAR GENETICS AND METABOLISM
- New avenues for anti-epileptic drug discovery and development
- (2013) Wolfgang Löscher et al. NATURE REVIEWS DRUG DISCOVERY
- Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment
- (2013) Scott C. Baraban et al. Nature Communications
- HCN channelopathies: pathophysiology in genetic epilepsy and therapeutic implications
- (2011) Christopher A Reid et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapy for hyperthermia-induced seizures in Scn1a mutant rats
- (2011) Keiichiro Hayashi et al. EPILEPSIA
- Epilepsy Care in Developing Countries: Part I of II
- (2010) Gretchen L. Birbeck Epilepsy Currents
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile
- (2008) Susana E. Camposano et al. EPILEPSIA
- Anticonvulsant effects of the BK-channel antagonist paxilline
- (2008) Jesse J. Sheehan et al. EPILEPSIA
- ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007
- (2008) C Sue Richards et al. GENETICS IN MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started